Relmada Therapeutics (RLMD.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov14

Relmada Therapeutics released FY2025 9 Months earnings on November 13 After-Market EST, actual revenue USD 0, actual EPS USD -1.1787

00:00

Relmada Therapeutics released FY2025 Q3 earnings on November 13 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.304 (forecast USD -0.04)

00:00

Nov6

Relmada Therapeutics to Release FY2025 Q3 Earnings on November 13 After-Market (EST), Forecast EPS -0.04 USD

00:07

Aug7

Relmada Therapeutics released FY2025 Q2 earnings on August 7 After-Market EST: Actual Revenue USD 0, Actual EPS USD -0.3 (Forecast EPS USD -0.04)

23:00

Relmada Therapeutics released FY2025 Semi-Annual earnings on August 7 After-Market (EST), actual revenue USD 0, actual EPS USD -0.8622

23:00

Jul31

Relmada Therapeutics to release FY2025 Q2 earnings report on August 7 After-Market EST, forecast EPS USD -0.04

00:08

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -10.09 M, EPS -0.304

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -9.866 M, EPS -0.2972

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -17.56 M, EPS -0.5774

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More